CPT code 30200 represents a therapeutic turbinate(s) injection (intraturbinal injection), a minimally invasive intranasal procedure used to address rhinorrhea, nasal obstruction, and sleep-related nasal issues. Nationally, this code is relevant to otolaryngology, allergy/immunology, and sleep medicine providers who treat chronic nasal symptoms that may not respond to medical therapy alone. The procedure’s utilization has implications for outpatient procedural workflows and payer coverage policies for intranasal interventions.

Key payers covered in this publication include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, typical sites of service, and commonly used modifiers where available. The report outlines benchmarks for utilization and reimbursement patterns when available, summarizes recent policy or coding guidance applicable to intranasal therapeutic procedures, and highlights coding and billing considerations relevant to outpatient and office-based settings.

This summary is intended to inform billing staff, coding professionals, and clinical leaders about the clinical purpose of CPT code 30200, the payer landscape, and the types of policy and operational issues that commonly arise with intraturbinal injections. Data not available in the input will be noted where applicable.